Small-diameter defibrillation electrodes: Can they take a licking and keep hearts ticking?

Heart Rhythm

Volumn 4, Issue 7, 2007, Pages 900-903

  Swerdlow, Charles D ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC IMPEDANCE; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; EARLY DIAGNOSIS; EDITORIAL; ELECTRODE; ELECTROGRAPHY; EQUIPMENT DESIGN; FOLLOW UP; FREQUENCY ANALYSIS; HEART PROARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MATERIALS TESTING; MEDICAL AUDIT; PHYSICIAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; STANDARD; TREATMENT FAILURE;

ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; HUMANS;

EID: 34250887439     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.05.001     Document Type: Editorial

References (23)

1. Hauser R.G., Kallinen L., Almquist A., Gornick C., and Katsiyiannis W. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 4 (2007) 892-896
2. Groves R. Physician information. Sprint Fidelis lead. Medtronic. March 21, 2007. Available at http://www.medtronic.com/Sprint_Fidelis_leads.pdf. Accessed April 21, 2007.
3. Maloney J.D., Hayes D.L., Timmis G.C., and The Writing Committee. Report of the Policy Conference of NASPE on device/lead performance and the development of a postmarket surveillance database. Pacing Clin Electrophysiol 16 (1993) 1945-1952
4. Carlson M.D., Wilkoff B.L., Maisel W.H., Carlson M.D., Ellenbogen K.A., Saxon L.A., Prystowsky E.N., Alpert J.S., Cain M.E., Ching E.A., Curtis A.B., Davies D.W., Hammill S.C., Hauser R.G., Lampert R., and Zipes D.P. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm 3 (2006) 1250-1273
5. Pratt T.R., Pulling C.C., and Stanton M.S. Prospective postmarket device studies versus returned product analysis as a predictor of system survival. Pacing Clin Electrophysiol 23 (2000) 1150-1155
6. Lenter C. Exact confidence limits for p. Geigy Scientific Tables (1982), Ciba-Geigy Corporation, West Caldwell, NJ 89-102
7. Medtronic Inc. Cardiac rhythm disease management product performance report. January 31, 2007. Available at http://www.medtronic.com/crm/performance/leads/defib/index.html. Accessed April 22, 2007.
8. Swerdlow C.D., and Friedman P.A. Advanced ICD troubleshooting. Part 2. Pacing Clin Electrophysiol 29 (2006) 70-96
9. Swerdlow C., and Shivkumar K. Implantable cardioverter defibrillators: clinical aspects. In: Zipes D.P., and Jalife J. (Eds). Cardiac Electrophysiology: From cell to bedside. 4th ed (2004), W. B. Saunders, Philadelphia 980-993
10. Gunderson B.D., Patel A.S., Bounds C.A., and Ellenbogen K.A. Automatic identification of clinical lead dysfunctions. Pacing Clin Electrophysiol 28 Suppl 1 (2005) S63-S67
11. Vollmann D., Erdogan A., Himmrich E., Neuzner J., Becker D., Unterberg-Buchwald C., and Sperzel J. Patient alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms. Europace 8 (2006) 371-376
12. Becker R., Ruf-Richter J., Senges-Becker J.C., Bauer A., Weretka S., Voss F., Katus H.A., and Schoels W. Patient alert in implantable cardioverter defibrillators: toy or tool?. J Am Coll Cardiol 44 (2004) 95-98
13. Schoenfeld M.H., Compton S.J., Mead R.H., Weiss D.N., Sherfesee L., Englund J., and Mongeon L.R. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 27 (2004) 757-763
14. Gunderson B.D., Abeyratne A.I., Olson W.H., and Swerdlow C.D. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks. Pacing Clin Electrophysiol 30 (2007) 157-165
15. Wilkoff B.L., Stern R., Williamson B., Wathen M., Holloman K., Fieberg A., and Brown M. Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity. Trials 7 (2006) 18 [NCT00279279]
16. Swerdlow C.D., Shehata M., and Chen P.S. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. Pacing Clin Electrophysiol 30 (2007) 258-270
17. Gunderson B.D., Gillberg J.M., Wood M.A., Vijayaraman P., Shepard R.K., and Ellenbogen K.A. Development and testing of an algorithm to detect imlantable cardioverter-defibrillator lead failure. Heart Rhythm 3 (2006) 155-162
18. Gunderson B.D., Patel A.S., Bounds C.A., Shepard R.K., Wood M.A., and Ellenbogen K.A. An algorithm to predict implantable cardioverter-defibrillator lead failure. J Am Coll Cardiol 44 (2004) 1898-1902
19. McVenes R. Personal communication. April 20, 2007.
20. Danik S.B., Mansour M., Singh J., Reddy V.Y., Ellinor P.T., Milan D., Heist E.K., d'Avila A., Ruskin J.N., and Mela T. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 4 (2007) 439-442
21. Wilkoff B.L. Pacemaker and ICD malfunction-an incomplete picture. JAMA 295 (2006) 1944-1946
22. Hauser R.G., and Maron B.J. Lessons from the failure and recall of an implantable cardioverter-defibrillator. Circulation 112 (2005) 2040-2042
23. Swerdlow C.D., and Cannom D.S. ICD product reliability: lessons from electrical overstress failures. Pacing Clin Electrophysiol 24 (2001) 1043-1045